Evidence map›Paper›PMID 39931110›Full record

SynthesisWellcome open research2024

Progress on implementing the WHO-GLASS recommendations on priority pathogen-antibiotic sensitivity testing in Africa: A

Mackline Hope, Reuben Kiggundu, Dickson Tabajjwa, Conrad Tumwine, Fahad Lwigale, Herman Mwanja, J P Waswa, Jonathan Mayito, Daniel Bulwadda, Dathan M Byonanebye and 2 more

Abstract readSystematic Review
In one paragraph

Synthesis in Wellcome open research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Antimicrobial resistance inScience in One Health · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mackline HopeInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.ORCID https://orcid.org/0000-0002-2593-8930
Reuben KiggunduInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.
Dickson TabajjwaInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.
Conrad TumwineInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.
Fahad LwigaleInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.ORCID https://orcid.org/0000-0002-1149-7820
Herman MwanjaInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.
J P WaswaManagement Sciences for Health Uganda, Kampala, Central Region, Uganda.
Jonathan MayitoInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.
Daniel BulwaddaInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.
Dathan M ByonanebyeInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.
Francis KakoozaInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.
Andrew KambuguInfectious Diseases Institute, Makerere University, Kampala, Central Region, Uganda.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Introduction: The World Health Organization global antimicrobial resistance surveillance system (GLASS) was rolled out in 2015 to guide antimicrobial resistance (AMR) surveillance. However, its implementation in Africa has not been fully evaluated. We conducted a scoping review to establish the progress of implementing the WHO 2015 GLASS manual in Africa. Methods: We used MeSH terms to comprehensively search electronic databases (MEDLINE and Embase) for articles from Africa published in English between January 2016 and December 2023. The Arksey and O'Malley's methodological framework for scoping reviews was employed. Data were collected on compliance with WHO GLASS recommendations for AMR surveillance-priority samples, pathogens, and pathogen-antibiotic combinations and analysed using Microsoft Excel. Results: Overall, 13,185 articles were identified. 7,409 were duplicates, and 5,141 articles were excluded based on titles and abstracts. 609 full-text articles were reviewed, and 147 were selected for data extraction. Of the 147 selected articles, 78.9% had been published between 2020 and 2023; 57.8% were from Eastern Africa. 93.9% of articles were on cross-sectional studies. 96.6% included only one priority sample type; blood (n=56), urine (n=64), and stool (n=22). Of the 60 articles that focused on blood as a priority sample type, 71.7%, 68.3%, 68.3%, 36.7%, 30%, and 10% reported recovery of Conclusion: Progress has been made in implementing the GLASS recommendations in Africa, but adoption varies across countries limiting standardisation and comparability of data.

Indexed as

Antimicrobial resistance; GLASS implementation; AMR Surveillance; Africa

Identifiers

PMID39931110
PMCPMC11809157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.